Linked from

The 14 pages that link to Cancer immunotherapy, each with the reason it gives.

• Antigen presentationRelated: Tumor peptide display can expose cancer cells to T-cell attack and guide immunotherapy.

• Major histocompatibility complexRelated: Many T-cell therapies depend on tumor peptides being displayed by MHC molecules.

• ImmunotherapyBroader topic: Cancer is the most prominent setting for therapies that release or engineer immune attack.

• LymphomaNarrower topic: Lymphoma research tests ways to direct immune responses beyond established antibody and cell therapies.

• Dendritic cellNarrower topic: Dendritic-cell vaccines are one strategy for directing antitumor T-cell responses.

• Natural killer cellNarrower topic: NK-cell therapies are one branch of immune-based cancer treatment.

• ImmunodeficiencyCompared with: It deliberately strengthens or redirects immunity, opposite the deficient protection at issue here.

• Pattern recognition receptorRelated: Activating innate sensors can strengthen antitumor immunity and shape responses to therapy.

• Cancer researchRelated: It applies findings about tumor–immune interactions to treatment.

• Pancreatic cancerRelated: Most pancreatic cancers respond poorly to current immunotherapies, prompting efforts to alter the tumor environment.

• Antigen-presenting cellRelated: Tumor-antigen presentation can shape T-cell responses targeted by these treatments.

• CureRelated: Some immune responses can eradicate cancer cells and produce lasting remission.

• Ralph M. SteinmanNarrower topic: Steinman’s research helped motivate therapeutic strategies that enlist dendritic cells against cancer.

• Tasuku HonjoNarrower topic: Honjo’s PD-1 research helped establish checkpoint blockade as a treatment strategy.